BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.90
Delayed Data
As of Feb 21
 -0.16 / -3.16%
Today’s Change
3.95
Today|||52-Week Range
9.25
-0.20%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close5.06
Today’s open5.10
Day’s range4.87 - 5.12
Volume804,844
Average volume (3 months)1,215,733
Market cap$482.2M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+5.71%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book229.08

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...-0.10-0.68%
CYADCelyad SA+1.53+3.72%
SELBSelecta Biosciences ...-0.30-3.41%
NSTGNanoString Technolog...-0.14-2.05%
Data as of 4:00pm ET, 02/21/2018

Financials

Last reporting dateFebruary 20, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts